Latest papers

Relative potencies of antagonists of the luteinizing hormone releasing hormone with Lys8 and Arg8 and substitutions in positions 3, 5, 6, 7 and 8.

The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): A concurrent microdialysis and plasma analysis study.

Factors Affecting the Aldosterone/Renin Ratio.

Synthesis and antihormonal properties of novel 11β-benzoxazole-substituted steroids

Design, synthesis and biological activity of new neurohypophyseal hormones analogues conformationally restricted in the N-terminal part of the molecule. Highly potent OT receptor antagonists.

8-Phenylthio-adenines stimulate the expression of steroid hydroxylases, Cav3.2 Ca2+ channels, and cortisol synthesis by a cAMP-independent mechanism

Neuropeptides of the cotton fleahopper, Pseudatomoscelis seriatus (Reuter).

Tissue-selective estrogen complex bazedoxifene and conjugated estrogens for the treatment of menopausal vasomotor symptoms.

Engineering and optimization of an allosteric biosensor protein for peroxisome proliferator-activated receptor γ ligands.

Serum leptin, thyroxine and thyroid-stimulating hormone levels interact to affect cognitive function among US adults: evidence from a large representative survey

Synthesis and in vivo evaluation of (S)-6-(4-fluorophenoxy)-3-((1-[11C]methylpiperidin-3-yl)methyl)-2-o-tolylquinazolin-4(3H)-one, a potential PET tracer for growth hormone secretagogue receptor (GHSR)

Analogs of the CLV3 Peptide: Synthesis and Structure-Activity Relationships Focused on Proline Residues.

Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic properties.

Agonist-Specific Requirement For A Glutamate In Transmembrane Helix 1 Of The Oxytocin Receptor.

Substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonist: a review.

Development and characterization of high-affinity leptins and leptin antagonists.

Synthetic and Mechanistic Pathways of Cis and Trans-Hydroxytamoxifen Drug Derivatives Reacting with Cp*Rh Complexes that involve η(1)-N, η(2)-N,O, η(1)-O, and η(6) Bonding Modes, via a Novel N-π Rearrangement; Relative Binding Affinities and Computer Docking Studies of Cis and Trans-η(6)-Cp*Rh-Hydroxytamoxifen Complexes at the Estrogen, ERα and ERβ Receptors, and Growth Inhibition to Breast Cancer Cells.

Novel Helix-Constrained Nociceptin Derivatives Are Potent Agonists and Antagonists of ERK Phosphorylation and Thermal Analgesia in Mice.

Interleukin 1 receptor antagonist is associated with changes in body composition during physiological GH substitution in patients with adult-onset growth hormone deficiency.

Development of prolactin receptor antagonists with reduced pH-dependence of receptor binding.